​​

1. Abushanab D, Al-Badriyeh D, AL-Maridi W, Abdul Rouf PV, Al Hail M, ElKassem W, Thomas B, Alsoub H, Hanssens Y, El Enany R. Cost-Benefit Analysis of Antimicrobial Stewardship Program in the Adult General Medicine Setting in Qatar. Qatar Health Congress 2023 and the 3rd Qatar Public Health Conference (November 2023). Doha, Qatar. (Podium)
2. Abushanab D, Chbib S, Kaddoura R, Al Hai M, Abdul Rouf PV, El-Kassem W, Shah J, Nair R, Al-Badriyeh D. Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction in patients without diabetes in Qatar. Qatar Health Congress 2023 and the 3rd Qatar Public Health Conference (November 2023). Doha, Qatar. (Podium)
3. Abushanab D, Al-Dewik N, AlNasr R, Mohammed H, AlNaama A, Al-Hail M, Farrell T, Elkassem W, Abdulrouf PV, Thomas B, Al-Badriyeh D. Cost-Effectiveness of Fetal Fibronectin Testing to Predict Preterm Birth in Pregnant Women with Symptoms of Premature Labour. Qatar Health Congress 2023 and the 3rd Qatar Public Health Conference (November 2023). Doha, Qatar. (Podium)
4. Abushanab D, Al-Badriyeh D, Marquina C, Liew D, Ademi Z. Societal Health and Economic Burden of Cardiovascular Diseases in the Population with Type 2 Diabetes in Qatar. A 10-Year Forecasting Model. Qatar Health Congress 2023 and the 3rd Qatar Public Health Conference (November 2023). Doha, Qatar. (Podium)
5. Abushanab D, Al-Badriyeh D, AL-Maridi W, Abdul Rouf PV, Al Hail M, ElKassem W, Thomas B, Alsoub H, Hanssens Y, El Enany R. Cost-Benefit Analysis of Antimicrobial Stewardship Program in the Adult General Medicine Setting in Qatar. 6th Qatar International Pharmacy Conference (November 2023). Doha, Qatar. (Poster)
6. Saadia H, Mustafa M, Abushanab D, Kaddoura R, Thomas B, Abdul Rouf PB, Elkassem W, Al Hail M, Al-Badriyeh D. Cost-Benefit Analysis of the Antimicrobial Stewardship Program in the Heart Hospital of Hamad Medical Corporation in Qatar. Qatar Health Congress 2023 and the 3rd Qatar Public Health Conference (November 2023). Doha, Qatar. (Poster)
7. Elshafey N, Al-Badriyeh D, Mekkawi R, Al Hail M, Abdul Rouf PV, Elkassem W, Thomas B, Abushanab D. Cost-Benefit Analysis of Antimicrobial Stewardship Program Maturity in Adult Surgical Ward Settings: A Retrospective Study in Qatar. Qatar Health Congress 2023 and the 3rd Qatar Public Health Conference (November 2023). Doha, Qatar. (Poster)
8. Moustafa D, Abushanab A, Sankar BA, Nasr Z, Al Hail M, Hamad A, Abdul Rouf PV, Elkassem W, Thomas B, Al-Badriyeh D. Cost-benefit analysis of antimicrobial stewardship program in a cancer setting in Qatar. Qatar Health Congress 2023 and the 3rd Qatar Public Health Conference (November 2023). Doha, Qatar. (Poster)
9. Shafei L, Al-Badriyeh D, Thomas B, Al Hail M, Abdul Rouf PV, El-Kassem W, Alsoub H, Abushanab D. Cost-benefit Analysis Of Antimicrobial Stewardship Program In Women’s Health At Hamad Medical Corporation In Qatar. 6th Qatar International Pharmacy Conference (November 2023). Doha, Qatar. (Poster)
10. Saadia H, Mustafa M, Abushanab D, Kaddoura R, Thomas B, Abdul Rouf PB, Elkassem W, Al Hail M, Al-Badriyeh D. Cost-Benefit Analysis of the Antimicrobial Stewardship Program in the Heart Hospital of Hamad Medical Corporation in Qatar. 6th Qatar International Pharmacy Conference (November 2023). Doha, Qatar. (Poster)
11. Moustafa D, Abushanab A, Sankar BA, Nasr Z, Al Hail M, Hamad A, Abdul Rouf PV, Elkassem W, Thomas B, Al-Badriyeh D. Cost-benefit analysis of antimicrobial stewardship program in a cancer setting in Qatar. 6th Qatar International Pharmacy Conference (November 2023). Doha, Qatar. (Poster)
12. Abushanab D, Chbib S, Kaddoura R, Al Hai M, Abdul Rouf PV, El-Kassem W, Shah J, Nair R, Al-Badriyeh D. Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction in patients without diabetes in Qatar. 6th Qatar International Pharmacy Conference (November 2023). Doha, Qatar. (Poster)
13. Abushanab D, Al-Dewik N, AlNasr R, Mohammed H, AlNaama A, Al-Hail M, Farrell T, Elkassem W, Abdulrouf PV, Thomas B, Al-Badriyeh D. Cost-Effectiveness of Fetal Fibronectin Testing to Predict Preterm Birth in Pregnant Women with Symptoms of Premature Labour. 6th Qatar International Pharmacy Conference (November 2023). Doha, Qatar. (Poster)
14. Saadia H, Mustafa M, Abushanab D, Kaddoura R, Thomas B, Abdul Rouf PB, Elkassem W, Al Hail M, Al-Badriyeh D. Cost-Benefit Analysis of the Antimicrobial Stewardship Program in the Heart Hospital of Hamad Medical Corporation in Qatar. 5th International Primary Health Care Conference (November 2023). Doha, Qatar. (Poster)
15. Al-Badriyeh D, Abounahia F, Al-Shaibi S, Alkhateeb M, AlBaridi A, Abu Jarir R, Sabouni A, Paramban R, Alhersh E, Ibrahim L, Awad K, Alansari R, Abushanab D. Analgesia Versus No-Analgesia in the Management of Neonates Undergoing Mechanical Ventilation in the Intensive Care Setting in Qatar. A Cost-Effectiveness Analysis. 39th International Conference for Pharmacoepidemiology (August 2023). Halifax, Canada. (Poster)
16. Al-Shaibi S, Abushanab D, Abounahia F, Awaisu A, Al-Badriyeh D. Cost-effectiveness analysis of ibuprofen versus indomethacin or paracetamol for the treatment of patent ductus arteriosus in preterm neonates. 39th International Conference for Pharmacoepidemiology (August 2023). Halifax, Canada. (Poster)
17. Abushanab D, Chbib S, Kaddoura R, Al Hai M1, Abdul Rouf PV, El-Kassem W, Shah J, Nair R, Al-Badriyeh D. Cost‑effectiveness evaluation of add‑on dapagliflozin for heart failure with reduced ejection fraction among patients without type 2 diabetes. 39th International Conference for Pharmacoepidemiology (August 2023). Halifax, Canada. (Poster)
18. Abushanab D, Al-Badriyeh D, Rijims M, Abdul Rouf P, Al Hail M, Elkassem W, Abdelaal M. Economic Impact of clinical pharmacist interventions in the Neonatal Intensive Care Unit in Qatar. International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 2023 conference (May 2023), Boston, MA, USA. (Poster)
19. Abushanab D, Al-Badriyeh D, Abdul Rouf P, Al Hail M, Elkassem W, Thomas B, Elshafey N, Eljilany I. Impact of clinical pharmacist interventions on economic outcomes in Women's Wellness and Research Center in Qatar. International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 2023 conference (May 2023), Boston, MA, USA. (Poster)
20. Abushanab D, Al-Badriyeh D, Almarridi W, Al Hail M, Abdul Rouf P, Elkassem W, Thomas B, Al Soub H, Hanssens Y, El Enany R. The economic impact of antimicrobial stewardship program in the adults’ general medicine setting in Qatar. International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 2023 conference (May 2023), Boston, MA, USA. (Poster)
21. Abushanab D, Nasr Z, Al-Badriyeh D. Efficacy and safety of colistin versus tigecycline for multidrug-resistant and extensively drug-resistant gram-negative pathogens: A meta-analysis. American College of Clinical Pharmacy (ACCP) Global Conference on Clinical Pharmacy (October 2022). California, USA. (Poster)
22. Abushanab D, Atchan M, Elajez R, Nabil M, Abdelbari A, Al HM, Abdul Rouf P, Elkassem W, Diab MI, Al-Badriyeh D. Economic impact of pharmacist participation in clinical rounds at a general tertiary hospital in Qatar. Virtual International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 2022 conference (June 2022), USA. (Virtual Poster)
23. Kaddoura R, Abushanab D, Arabi AR, Al-Badriyeh D. Cost-effectiveness analysis of sacubitril/valsartan in implantable cardioverter-defibrillator eligible patients. Virtual International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 2022 conference (June 2022), USA. (Virtual Poster)
24. AlMukdad S, Kaddoura R, Arabi AR, AlMaraghi F, Al-Saadi Al Yafei S, Al-Badriyeh D. Cost-effectiveness of evolocumab versus standard therapy for the treatment of dyslipidemia in patients with cardiovascular disease in Qatar. Virtual International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 2022 conference (June 2022), USA. (Virtual Poster)
25. Abushanab D, Gulied A, Hamad A, Abdul Rouf P, Al Hail M, Elkassem W, El Hajj M, Al-Badriyeh D. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer. Virtual International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 2022 conference (June 2022), USA. (Virtual Poster)
26. Alhersh E, Rainkie D, Abushanab D, Al-Badriyeh D. A Cost-effectiveness analysis for high versus low dose caffeine for the treatment of apnea in neonatal intensive care unit. Virtual International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 2022 conference (June 2022), USA. (Virtual Poster)
27. Abushanab D, Liew D, Marquina C, Al-Badriyeh D, Ademi Z. First-line Treatment with empagliflozin and metformin combination versus standard care for patients with type 2 diabetes mellitus and cardiovascular disease in Qatar. A cost-Effectiveness analysis. Qatar Health 2022/2nd Qatar Public Health (February 2022), Qatar. (Virtual Oral Presentation)
28. Abushanab D, Al-Badriyeh D, Liew D, Ademi Z. Cost-effectiveness of non-statin lipid-modifying agents for primary and secondary prevention of cardiovascular disease among patients with type 2 diabetes mellitus: A systematic review. Qatar Health 2022/2nd Qatar Public Health (February 2022), Qatar. (Virtual Poster)
29. Abushanab D, Kaddoura R, Al-Badriyeh D. Cost-effectiveness analysis of dapagliflozin in addition to standard therapy in heart failure with reduced ejection fraction: A Qatari healthcare perspective. Qatar Health 2022/2nd Qatar Public Health (February 2022), Qatar. (Virtual Oral Presentation)